Why is a lifesaving Malaria drug in Africa losing its effectiveness?

A new study has revealed alarming evidence of partial resistance to artemisinin, a crucial antimalarial drug, in Ugandan children with severe malaria. This resistance could hinder the effectiveness of current treatments, potentially leading to increased malaria-related deaths, particularly among vulnerable young children in Africa.